CME Group Inc. (NASDAQ:CME – Free Report) – Research analysts at Zacks Research upped their Q4 2024 earnings per share estimates for shares of CME Group in a research note issued on Wednesday, November 13th. Zacks Research analyst T. De now forecasts that the financial services provider will earn $2.47 per share for the quarter, up from their previous estimate of $2.31. The consensus estimate for CME Group’s current full-year earnings is $10.23 per share. Zacks Research also issued estimates for CME Group’s Q1 2025 earnings at $2.57 EPS, Q2 2025 earnings at $2.50 EPS, Q3 2025 earnings at $2.57 EPS, FY2025 earnings at $10.19 EPS, Q1 2026 earnings at $2.75 EPS, Q2 2026 earnings at $2.71 EPS, Q3 2026 earnings at $2.44 EPS and FY2026 earnings at $10.62 EPS.
CME Group (NASDAQ:CME – Get Free Report) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The company had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the prior year, the business earned $2.25 earnings per share. The firm’s revenue for the quarter was up 18.4% on a year-over-year basis.
Get Our Latest Stock Report on CME
CME Group Stock Up 0.8 %
NASDAQ CME opened at $225.28 on Friday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. The company has a market cap of $81.12 billion, a price-to-earnings ratio of 23.69, a PEG ratio of 5.26 and a beta of 0.55. The company has a 50 day moving average of $222.62 and a 200-day moving average of $210.37. CME Group has a 1-year low of $190.70 and a 1-year high of $230.36.
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the company. Truvestments Capital LLC bought a new stake in shares of CME Group in the 3rd quarter worth approximately $26,000. Dunhill Financial LLC grew its stake in shares of CME Group by 188.4% in the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 81 shares during the last quarter. Y.D. More Investments Ltd bought a new position in shares of CME Group during the second quarter valued at $36,000. Thurston Springer Miller Herd & Titak Inc. raised its position in shares of CME Group by 62.2% in the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after purchasing an additional 74 shares during the last quarter. Finally, McClarren Financial Advisors Inc. boosted its stake in CME Group by 66.1% in the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after purchasing an additional 78 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.
Insider Buying and Selling
In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This represents a 5.38 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. This represents a 12.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 15,621 shares of company stock worth $3,441,063. Corporate insiders own 0.30% of the company’s stock.
CME Group Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be issued a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.04%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s dividend payout ratio is currently 48.37%.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- Upcoming IPO Stock Lockup Period, Explained
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Where Do I Find 52-Week Highs and Lows?
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- What Are the FAANG Stocks and Are They Good Investments?
- Time to Load Up on Home Builders?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.